Rightsmile, Inc. (RIGH)

[john12341]

this is from the righ fillings righ is not doing any more financing through bcap.

Throughout 2013, the Company placed its focus on resolving market volatility allegedly resultant from
a former financing relationship with Baron Capital Enterprises (BCAP) and its principals, an entity and
individual(s) closely involved in providing past financing to the public entity prior to the 2012 reverse
merger, and to a lesser degree, minor financing during the Q1 2012 and Q2 2012 post reverse merger
period. BG Medical has no plans to enter into further debt arrangements with previous promissory note
holders. The company wishes to distance itself from BCAP and remains committed to preserving
shareholder value. Due to the disruptive nature of unwinding the aforementioned relationship(s), the
undertaking of preserving the Company’s future as an attractive investment prospect eclipsed daily
operations and affected previously scheduled technology development. With limited capital resources
available, guarding the long-term growth potential of the Company led to a reduction in near-term
revenues. These actions forced the introduction of leaner operation models that serve today as a
valuable and efficient blueprint for the company as it enters 2014, its fourth year in operation.

In Q4 2012, the Company completed debt obligations that had been negotiated in the previous quarter.
Upon completion, BG Medical reevaluated the relationship the company previously held with Baron
Capital Enterprises (BCAP), a debt holder in the Company, and consultant to debt holders associated
with the Company prior to the January 2012 reverse merger with BG Medical.[/
b] Executive management
concluded that financing commitments previously set forth by BCAP to BG Medical had not met
expectations. As a result of an internal study examining historical transactions, management further
alleged that ongoing actions by BCAP could cause irreparable harm to both Company and
shareholders. To protect shareholder interests and future business interests, the Company sought to
limit uncontrolled free trading shares from entering the marketplace from methodologies that that did
not support business growth and/or shareholder earnings. Stopgap measures were put into place that
limited corporate communications until a long-term strategy with sufficient resources had been
established. The resultant lack of capital financing as previously planned, coupled with the presence of
an unresolved capital financing relationship, created challenges for BG Medical in adhering to stated
growth projections that were dependent upon capital support. Furthermore, medical cannabis policy
changes in San Diego, CA and Long Beach, CA forced closure of key BudGenius.com clients and
prospective clients. These unexpected closures reduced Company profits due to significant resources
that had been invested into expanding client relationships within these regions. Evolving municipal
policy changes represent operational risks inherent to the medical cannabis

reference source
http://www.otcmarkets.com/financialReportViewer?symbol=RIGH&id=121610